Biological and diurnal variation in glucocorticoid sensitivity detected with a sensitive in vitro dexamethasone suppression of cytokine production assay

Journal of Clinical Endocrinology and Metabolism

Volumn 95, Issue 8, 2010, Pages 3657-3663

  Cardinal, John ^a   Pretorius, Carel J ^a   Ungerer, Jacobus P J ^a  

^a Pathology Queensland ^*  (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; DEXAMETHASONE; DNA; GLUCOCORTICOID RECEPTOR; INTERLEUKIN 6; NR3C1 PROTEIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CIRCADIAN RHYTHM; CONTROLLED STUDY; CYTOKINE PRODUCTION; DEXAMETHASONE SUPPRESSION TEST; DNA SYNTHESIS; DRUG SENSITIVITY; FEMALE; GENE MUTATION; GENE SEQUENCE; HETEROZYGOTE; HUMAN; IN VITRO STUDY; INCUBATION TIME; LYMPHOCYTE PROLIFERATION; MALE; MONOCYTE; PHENOTYPE; PRIORITY JOURNAL;

EID: 77955356226     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2009-2720     Document Type: Article

References (17)

1. Zhou J, Cidlowski JA 2005 The human glucocorticoid receptor: one gene, multiple proteins and diverse responses. Steroids 70:407-417
2. Charmandari E, Kino T, Ichijo T, Chrousos GP 2008 Generalized glucocorticoid resistance: clinical aspects, molecular mechanisms, and implications of a rare genetic disorder. J Clin Endocrinol Metab 93:1563-1572
3. McMahon SK, Pretorius CJ, Ungerer JP, Salmon NJ, Conwell LS, Pearen MA, Batch JA 2010 Neonatal complete generalized glucocorticoid resistance and growth hormone deficiency caused by a novel homozygous mutation in helix 12 of the ligand binding domain of the glucocorticoid receptor gene (NR3C1). J Clin Endocrinol Metab 95:297-302
4. Huizenga NA, de Lange P, Koper JW, de Herder WW, Abs R, Kasteren JH, de Jong FH, Lamberts SW 2000 Five patients with biochemical and/or clinical generalized glucocorticoid resistance without alterations in the glucocorticoid receptor gene. J Clin Endocrinol Metab 85:2076-2081
5. Corrigan CJ, Brown PH, Barnes NC, Szefler SJ, Tsai JJ, Frew AJ, Kay AB 1991 Glucocorticoid resistance in chronic asthma. Glucocorticoid pharmacokinetics, glucocorticoid receptor characteristics, and inhibition of peripheral blood T cell proliferation by glucocorticoids in vitro. Am Rev Respir Dis 144:1016-1025
6. Hearing SD, Norman M, Probert CS, Haslam N, Dayan CM 1999 Predicting therapeutic outcome in severe ulcerative colitis by measuring in vitro steroid sensitivity of proliferating peripheral blood lymphocytes. Gut 45:382-388
7. Farrell RJ, Kelleher D 2003 Mechanisms of steroid action and resistance in inflammation. J Endocrinol 178:339-346
8. Molijn GJ, Spek JJ, van Uffelen JC, de Jong FH, Brinkmann AO, Bruining HA, Lamberts SW, Koper JW 1995 Differential adaptation of glucocorticoid sensitivity of peripheral blood mononuclear leukocytes in patients with sepsis or septic shock. J Clin Endocrinol Metab 80:1799-1803
9. Duclos M, Gouarne C, Bonnemaison D 2003 Acute and chronic effects of exercise on tissue sensitivity to glucocorticoids. J Appl Physiol 94:869-875
10. DeRijk RH, Petrides J, Deuster P, Gold PW, Sternberg EM 1996 Changes in corticosteroid sensitivity of peripheral blood lymphocytes after strenuous exercise in humans. J Clin Endocrinol Metab 81:228-235
11. Hearing SD, Norman M, Smyth C, Foy C, Dayan CM 1999 Wide variation in lymphocyte steroid sensitivity among healthy human volunteers. J Clin Endocrinol Metab 84:4149-4154
12. Fraser CG, Harris EK 1989 Generation and application of data on biological variation in clinical chemistry. Crit Rev Clin Lab Sci 27: 409-437
13. Pai S, Thomas R 2008 Immune deficiency or hyperactivity-NF-κB illuminates autoimmunity. J Autoimmun 31:245-251
14. Mollah ZU, Pai S, Moore C, O'Sullivan BJ, Harrison MJ, Peng J, Phillips K, Prins JB, Cardinal J, Thomas R 2008 Abnormal NF-κB function characterizes human type 1 diabetes dendritic cells and monocytes. J Immunol 180:3166-3175
15. Kawai T, Akira S 2006 TLR signalling. Cell Death Differ 13:816-825
16. Bhattacharyya S, Brown DE, Brewer JA, Vogt SK, Muglia LJ 2007 Macrophage glucocorticoid receptors regulate Toll-like receptor 4-mediated inflammatory responses by selective inhibition of p38 MAP kinase. Blood 109:4313-4319
17. Ogawa S, Lozach J, Benner C, Pascual G, Tangirala RK, Westin S, Hoffmann A, Subramaniam S, David M, Rosenfeld MG, Glass CK 2005 Molecular determinants of cross-talk between nuclear receptors and Toll-like receptors. Cell 122:707-721